Evidence map›Paper›PMID 39543820›Full record

ArticleAnnals of clinical and translational neurology2024

Automated assessment of EEG background for neurodevelopmental prediction in neonatal encephalopathy.

Micheline Lagacé, Saeed Montazeri, Daphne Kamino, Eva Mamak, Linh G Ly, Cecil D Hahn, Vann Chau, Sampsa Vanhatalo, Emily W Y Tam

Abstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Micheline LagacéFaculty of Medicine, Clinician Investigator Program, University of British Columbia, Vancouver, British Columbia, Canada.ORCID 0000-0001-6660-9693
Saeed MontazeriBABA Center, Pediatric Research Center, Department of Clinical Neurophysiology, Children's Hospital, HUS imaging, HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Daphne KaminoProgram in Neurosciences and Mental Health, SickKids Research Institute, Toronto, Ontario, Canada.ORCID 0000-0003-4025-9263
Eva MamakDepartment of Psychology, The Hospital for Sick Children, Toronto, Ontario, Canada.
Linh G LyProgram in Neurosciences and Mental Health, SickKids Research Institute, Toronto, Ontario, Canada.
Cecil D HahnDivision of Neurology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Vann ChauDivision of Neurology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Sampsa VanhataloBABA Center, Pediatric Research Center, Department of Clinical Neurophysiology, Children's Hospital, HUS imaging, HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.ORCID 0000-0002-9771-7061
Emily W Y TamDivision of Neurology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0002-8764-5535

Funding

Neurological Outcome of Glycemia in Neonatal EncephalopathyR01HD101419 · NICHD · HOSPITAL FOR SICK CHLDRN (TORONTO) · PI TAM, EMILY WING YUN · 2020 to 2024
$790k
Academy of Finland 332017Academy of Finland 335788Academy of Finland 343498Canadian Institutes for Health Research MOP-133710Canadian Institutes for Health Research PJT-166076CLC NIH HHS R01 HD101419NICHD NIH HHS R01 HD101419SickKids FoundationSigrid Juselius Foundation and Pediatric Foundation (Finland)the EU under the H2020 Research and Innovation Programme (Marie Skłodowska-Curie grant agreement) INFANS Project 813483University of British Columbia Clinician Investigator Program
6 · The paper itself

Abstract

objectiveAssess the capacity of brain state of the newborn (BSN) to predict neurodevelopment outcomes in neonatal encephalopathy.

methodsTrends of BSN, a deep learning-based measure translating EEG background to a continuous trend, were studied from a three-channel montage long-term EEG monitoring from a prospective cohort of 92 infants with neonatal encephalopathy and neurodevelopmental outcomes assessed by Bayley Scales of Infant Development, 3rd edition (Bayley-III) at 18 months. Outcome prediction used categories "Severe impairment" (Bayley-III composite score ≤70 or death) or "Any impairment" (score ≤85 or death).

results"Severe impairment" was predicted best for motor outcomes (24 h area under the curve (AUC) = 0.97), followed by cognitive (36 h AUC = 0.90), overall (24 h AUC = 0.84), and language (24 h AUC = 0.82). "Any impairment" was best predicted for motor outcomes (12 h AUC = 0.95), followed by cognitive (24 h AUC = 0.85), overall (12 h AUC = 0.75), and language (12 and 24 h AUC = 0.68). Optimal BSN cutoffs for outcome predictions evolved with the postnatal age. Low BSN scores reached a 100% positive prediction of poor outcomes at 24 h of age.

interpretationBSN is an excellent predictor of adverse neurodevelopmental outcomes in survivors of neonatal encephalopathy after therapeutic hypothermia, even at 24 h of life. The trend provides a fully automated, objective, quantified, and reliable interpretation of EEG background. The high temporal resolution supports continuous bedside brain assessment and early prognostication during the initial dynamic recovery phase.

Indexed as

Brain DiseasesElectroencephalographyNeurodevelopmental DisordersDeep LearningFemaleHumansInfantInfant, NewbornInfant, Newborn, DiseasesMalePrognosisProspective Studies

Identifiers

PMID39543820
PMCPMC11651191

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.